Functional analysis of - 351 interleukin-9 promoter polymorphism reveals an activator controlled by NF-κB

Genes and Immunity

Volumn 10, Issue 4, 2009, Pages 341-349

  Early, S B ^a   Huyett, P ^a   Brown Steinke, K ^a   Borish, L ^a   Steinke, J W ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 9;

ADULT; ANTIGEN BINDING; ARTICLE; ATOPY; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA SEQUENCE; FUNCTIONAL GENOMICS; GENE FREQUENCY; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IN VIVO STUDY; INFECTION; MALIGNANT NEOPLASTIC DISEASE; PARASITOSIS; PRIORITY JOURNAL; PROMOTER REGION; WILD TYPE;

ADOLESCENT; ADULT; ALLELES; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-9; JURKAT CELLS; MIDDLE AGED; NF-KAPPA B; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 67349232295     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.28     Document Type: Article

References (34)

1. Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol 2003; 111: S460-S475.
2. Hultner L, Moeller J. Mast cell growth-enhancing activity (MEA) stimulates interleukin 6 production in a mouse bone marrow-derived mast cell line and a malignant subline. Exp Hematol 1990; 18: 873-877.
3. Renauld J-C, Kermouni A, Vink A, Louahed J, Van Snick J. Interleukin-9 and its receptor: Involvement in mast cell differentiation and T cell oncogenesis. J Leukoc Biol 1995; 57: 353-360.
4. Louahed J, Kermouni A, Van Snick J, Renauld J-C. IL-9 induces expression of granzymes and high-affinity IgE receptor in murine T helper clones. J Immunol 1995; 154: 5061-5070.
5. Hultner L, Druez C, Moeller J, Uyttenhove C, Schmitt E, Rüde E et al. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/ TCGFIII (interleukin 9). Eur J Immunol 1990; 20: 1413-1416.
6. Gounni AS, Gregory B, Nutku E, Aris F, Latifa K, Minshall E et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood 2000; 96: 2163-2171.
7. Erpenbeck VJ, Hohlfeld JM, Volkmann B, Hagenberg A, Geldmacher H, Braun A et al. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol 2003; 111: 1319-1327.
8. Dong Q, Louahed J, Vink A, Sullivan CD, Messler CJ, Zhou Y et al. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur J Immunol 1999; 29 2130-2139.
9. Louahed J, Toda M, Jen J, Hamid Q, Renauld JC, Levitt RC et al. Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 2000; 22: 649-656.
10. Merz H, Houssiau FA, Orscheschek K, Renauld JC, Fliedner A, Herin M et al. Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 1991; 78: 1311-1317.
11. Bleeker ER, Amelung PJ, Levitt RC, Postma DS, Meyers DA. Evidence for linkage of total serum IgE and bronchial hyperresponsiveness to chromosome 5q: A major regulatory locus important in asthma. Clin Exp Allergy 1995; 25: S84-S88.
12. Doull IJ, Lawrence S, Watson M, Begishvili T, Beasley RW, Lampe F et al. Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperreponsiveness. Am J Respir Crit Care Med 1996; 153: 1280-1284.
13. Nicolaides NC, Holroyd KJ, Ewart SL, Eleff SM, Kiser MB, Dragwa CR et al. Interleukin 9: A candidate gene for asthma. Proc Natl Acad Sci 1997; 94: 13175-13180.
14. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994; 264: 1152-1156.
15. Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998; 158: 1958-1962.
16. Steinke JW, Barekzi E, Hagman J, Borish L. Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by Sp1. J Immunol 2004; 173: 3215-3222.
17. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 25(Suppl. 2): 74-78.
18. Song Z, Casolaro V, Chen R, Georas SN, Monos D, Ono SJ. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol 1996; 156: 424-429.
19. LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD et al A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001; 167: 5838-5844.
20. Nickel RG, Caslaro V, Wahn U, Beyer K, Barnes KC, Plunkett BS et al Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000; 164: 1612-1616.
21. Yao T, Kuo M, See L, Chen LC, Yan DC, Ou LS et al. The RANTES promoter polymorphism: A genetic risk factor for near-fatal asthma in Chinese children. J Allergy Clin Immunol 2003; 111: 1285-1292.
22. Mormann M, Rieth H, Hua TD, Assohou C, Roupelieva M, Hu SL et al. Mosaics of gene variations in the interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun 2004; 5: 246-255.
23. Steinke JW, Barekzi E, Huyett P, Borish L. Differential interleukin-10 production stratified by a571 promoter polymorphism in purified human immune cells. Cell Immunol 2007; 249: 101-107.
24. Stassen M, Muller C, Arnold M, Hültner L, Klein-Hessling S, Neudörfl C et al. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-κB is decisively involved in the expression of IL-9. J Immunol 2001; 166: 4391-4398.
25. Baldwin Jr AS. The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 1996; 14: 649-681.
26. Kuriyan J, Thanos D. Structure of the NF-κB transcription factor: A holistic interaction with DNA. Structure 1995; 3: 135-141.
27. Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC et al. IL-9 and its receptor in allergic and nonallergic disease: Increased expression in asthma. J Allergy Clin Immunol 2000; 105: 108-115.
28. Tsicopoulos A, Shimbara A, de Nadai P, Aldewachi O, Lamblin C, Lassalle P et al. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J Allergy Clin Immunol 2004; 113 462-469.
29. Faulkner H, Humphreys N, Renauld JC, Van Snick J, Grencis R. Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur J Immunol 1997; 27: 2536-2540.
30. Gilmelius I, Edstrom A, Amini RM, Fischer M, Nilsson G, Sundström C et al. IL-9 expression contributes to the cellular composition in Hodgkin lymphoma. Eur J Haematol 2006; 76: 278-283.
31. Wang TN, Chen WY, Huang YF, Shih NH, FengWW, Tseng HI et al. The synergistic effects of the IL-9 gene and environmental exposures on asthmatic Taiwanese families as determined by the transmission/ disequilibrium test. Int J Immunogenet 2006; 33: 105-110.
32. Steinke JW, Crouse CD, Bradley D, Hise K, Lynch K, Kountakis SE et al Characterization of interleukin-4 stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol 2004; 30: 212-219.
33. Hagman J, Travis A, Grosschedl R. A novel lineage-specific nuclear factor regulates mb-1 gene transcription at the early stages of B cell differentiation. EMBO J 1991; 10: 3409-3417.
34. Fitzsimmons D, Hodson W, Wheat W, Maira SM, Wasylyk B, Hagman J. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev 1996; 10: 2198-2211.